The “Squawk on the Street” team discusses Wall Street’s best August in 30 years. The Dow kicking off the week with three new constituents, Salesforce, Amgen and Honeywell will be included, replacing longtime component Exxon Mobil, Pfizer and Raytheon Technologies. Plus two major stock splits taking effect this morning from Apple & Tesla. Plus, David’s exclusive reporting on Steve Cohen’s bid for the New York Mets. Sources telling David that Cohen and the Mets are expected to reach a definitive agreement in the coming days. News on the COVID-19 vaccine and treatment front, as the Commissioner of the FDA said in an interview with the Financial Times that he’s willing to consider granting emergency authorization for a vaccine before clinical trials have been completed. Plus, the FDA expanding its emergency us of Gilead’s Remdesivir. Plus, David’s reporting on AT&T, sources telling him the company is in talks with PE firms about purchasing DirecTV aiming for a deal to be signed by the end of the year.
Learn more about your ad choices. Visit megaphone.fm/adchoices